[HTML][HTML] CD39 transforming cancer therapy by modulating tumor microenvironment
ABSTRACT CD39 is a pivotal enzyme in cancer, regulating immune response and tumor
progression via extracellular ATP and adenosine in the tumor microenvironment (TME) …
progression via extracellular ATP and adenosine in the tumor microenvironment (TME) …
[HTML][HTML] Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC)
T Del Giudice, N Staropoli, P Tassone, P Tagliaferri… - Cancers, 2024 - mdpi.com
Simple Summary Lung cancer is the most frequent cause of cancer-related death.
Unfortunately, only 30% of patients treated with immunotherapy gain any benefit; it is …
Unfortunately, only 30% of patients treated with immunotherapy gain any benefit; it is …
Therapy selection gets AI assistance
B THERINE, Y TE - nature.com
Cancer treatment outlook immune checkpoint proteins that cancers exploit to dodge
destruction. Arsela Prelaj, a thoracic oncologist at the National Institute of Tumours in Milan …
destruction. Arsela Prelaj, a thoracic oncologist at the National Institute of Tumours in Milan …